Taking a Closer Look at PCSK9 Part 2

If the new class of drugs are as effective as they appear to be in early studies, it could have a drastic affect on how patients with cardiac issues are treated in the future.

Jennifer Robinson, MD, MPH, from the University of Iowa discussed how the landscape could change with these new drugs and what it could mean to overall patient care at the American College of Cardiology's Annual Scientific Sessions and Expo in San Diego.